Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).

Win, Thida; Screaton, Nick; Porter, Joanna C; Ganeshan, Balaji; Maher, Toby M; Fraioli, Francesco; Endozo, Raymondo; Shortman, Robert I; Hurrell, Lynn; Holman, Beverley F; Thielemans, Kris; Rashidnasab, Alaleh; Hutton, Brian F; Lukey, Pauline T; Flynn, Aiden; Ell, Peter J; Groves, Ashley M

View / Open Files

Published version (PDF, 1Mb)

Authors

Win, Thida

Screaton, Nick

Porter, Joanna C

Ganeshan, Balaji

Maher, Toby M

Fraioli, Francesco

Endozo, Raymondo

Publication Date

2018-05

Journal Title

European journal of nuclear medicine and molecular imaging

ISSN

1619-7070

Volume

Issue

Pages

806-815

Language

eng

Type

Article

Physical Medium

Print-Electronic

Metadata

Show full item record

Citation

Win, T., Screaton, N., Porter, J. C., Ganeshan, B., Maher, T. M., Fraioli, F., Endozo, R., et al. (2018). Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).. European journal of nuclear medicine and molecular imaging, 45 (5), 806-815. https://doi.org/10.1007/s00259-017-3917-8

Keywords

Lung, Humans, Fluorodeoxyglucose F18, Positron-Emission Tomography, Tomography, X-Ray Computed, Risk Assessment, Aged, Middle Aged, Female, Male, Idiopathic Pulmonary Fibrosis, Positron Emission Tomography Computed Tomography

Identifiers

External DOI: https://doi.org/10.1007/s00259-017-3917-8

This record's URL: https://www.repository.cam.ac.uk/handle/1810/280641

Rights

Attribution 4.0 International

Licence URL: https://creativecommons.org/licenses/by/4.0/

Except where otherwise noted, this item's licence is described as Attribution 4.0 International